BAD logo

B.A.D. ETF (BAD) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist B.A.D. ETF (BAD) ein Financial Services-Unternehmen mit einer Bewertung von 0. Bewertet mit 44/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 17. März 2026
44/100 KI-Bewertung

B.A.D. ETF (BAD) Finanzdienstleistungsprofil

IPO-Jahr2021

B.A.D. ETF offers targeted exposure to specific sectors, including betting, alcohol, Canadian cannabis, and pharmaceuticals, through a passive indexing strategy. As a non-diversified fund, it aims to replicate the performance of its underlying index, appealing to investors seeking concentrated exposure to these industries.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

B.A.D. ETF presents a targeted investment vehicle for those seeking exposure to the betting, alcohol, cannabis, and pharmaceutical sectors. The fund's passive management approach aims to replicate the performance of its underlying index, offering a cost-effective way to invest in these industries. Key value drivers include the growth potential of the cannabis market, the resilience of the alcohol and pharmaceutical sectors, and the expansion of legalized betting and gambling. However, investors should be aware of the risks associated with the fund's non-diversified nature, which makes it susceptible to sector-specific downturns and regulatory changes. The ETF's performance is directly tied to the performance of the companies within its index, making it crucial to monitor the trends and developments within these industries.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • B.A.D. ETF focuses on a niche investment strategy, targeting betting, alcohol, cannabis, and pharmaceutical sectors.
  • The fund operates with a passive management approach, aiming to replicate the performance of its underlying index.
  • B.A.D. ETF is non-diversified, concentrating its investments in specific sectors, which can lead to higher volatility.
  • The fund's performance is directly linked to the growth and regulatory landscape of the betting, alcohol, cannabis, and pharmaceutical industries.
  • B.A.D. ETF offers investors a simplified way to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals).
  • Passive management approach.
  • Rules-based index.
  • Simplified way to gain exposure to a basket of companies within these sectors.

Schwaechen

  • Non-diversified nature.
  • Susceptibility to sector-specific downturns.
  • Reliance on regulatory landscape.
  • Potential for high volatility.

Katalysatoren

  • Upcoming: Further legalization of cannabis in additional states and countries.
  • Ongoing: Expansion of online betting and gambling markets.
  • Ongoing: Pharmaceutical companies within the fund achieving FDA approvals for new drugs.

Risiken

  • Potential: Regulatory changes negatively impacting the betting, alcohol, cannabis, and pharmaceutical industries.
  • Potential: Economic downturns reducing consumer spending on these products.
  • Ongoing: High volatility due to the fund's non-diversified nature.
  • Ongoing: Negative sentiment towards specific sectors affecting investor demand.

Wachstumschancen

  • Expansion of Legalized Betting and Gambling: The ongoing legalization of sports betting and online gambling in various jurisdictions presents a significant growth opportunity for B.A.D. ETF. As more states and countries legalize these activities, the companies within the ETF's betting and gambling sector are likely to experience increased revenue and profitability. This trend is expected to continue over the next 3-5 years, driving growth for the ETF. The global online gambling market is projected to reach $127.3 billion by 2027, according to a report by Allied Market Research.
  • Growth of the Cannabis Market: The increasing legalization and acceptance of cannabis for both medical and recreational purposes is a major growth driver for B.A.D. ETF. The ETF's exposure to Canadian cannabis companies allows it to capitalize on the expanding cannabis market. As more countries and regions legalize cannabis, the companies within the ETF's portfolio are expected to benefit from increased demand and market opportunities. The global legal cannabis market is projected to reach $90.4 billion by 2026, according to a report by Grand View Research.
  • Resilience of the Alcohol Sector: The alcohol industry is known for its resilience, even during economic downturns. B.A.D. ETF's exposure to alcohol companies provides a stable source of revenue and growth potential. The demand for alcoholic beverages remains consistent, making this sector a reliable component of the ETF's portfolio. The global alcoholic beverages market is projected to reach $1.6 trillion by 2025, according to a report by Statista.
  • Pharmaceutical Sector Innovation: The pharmaceutical industry is constantly innovating, with new drugs and therapies being developed to address various health conditions. B.A.D. ETF's exposure to pharmaceutical companies allows it to benefit from these advancements. The development and commercialization of new drugs can drive significant revenue growth for the companies within the ETF's portfolio. The global pharmaceutical market is projected to reach $1.57 trillion by 2028, according to a report by Fortune Business Insights.
  • Increased Investor Demand for Thematic ETFs: The growing popularity of thematic ETFs, which focus on specific sectors or trends, presents a growth opportunity for B.A.D. ETF. Investors are increasingly seeking targeted exposure to specific areas of the market, and thematic ETFs provide a convenient way to achieve this. As more investors allocate capital to thematic ETFs, B.A.D. ETF is likely to benefit from increased inflows and asset growth. The global thematic ETF market is projected to reach $400 billion by 2027, according to a report by ETFGI.

Chancen

  • Expansion of legalized betting and gambling.
  • Growth of the cannabis market.
  • Pharmaceutical sector innovation.
  • Increased investor demand for thematic ETFs.

Risiken

  • Regulatory changes in betting, alcohol, cannabis, and pharmaceutical sectors.
  • Economic downturns affecting consumer spending on these products.
  • Increased competition from other thematic ETFs.
  • Negative sentiment towards specific sectors.

Wettbewerbsvorteile

  • First-mover advantage in offering a unique combination of sector exposure.
  • Passive management approach provides cost-effectiveness.
  • Rules-based index ensures transparency and consistency.

Ueber BAD

B.A.D. ETF operates as a passively managed fund, designed to replicate the performance of a specific rules-based index. The fund's investment strategy focuses on providing exposure to a unique combination of sectors: betting or gambling companies, alcohol companies, Canadian cannabis companies (defined as those listed on Canadian exchanges, domiciled in Canada, or primarily operating there), and pharmaceutical companies. By tracking this index, B.A.D. ETF aims to deliver returns that mirror the collective performance of these industries, before accounting for fees and expenses. The fund's non-diversified nature means that its performance is heavily reliant on the performance of these specific sectors, making it a targeted investment vehicle for those with a particular interest in these areas. The fund's structure allows investors to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks, offering a simplified approach to investing in these industries.

Was das Unternehmen tut

  • Tracks a rules-based index focused on betting, alcohol, cannabis, and pharmaceutical companies.
  • Provides exposure to a portfolio of companies in specific sectors.
  • Offers a passive management approach, aiming to replicate the index's performance.
  • Invests in companies listed on Canadian exchanges, domiciled in Canada, or primarily operating in Canada within the cannabis sector.
  • Offers investors a simplified way to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks.
  • Operates as a non-diversified fund, concentrating its investments in specific sectors.

Geschaeftsmodell

  • Generates revenue through management fees charged to investors.
  • Aims to replicate the performance of its underlying index, providing returns to investors.
  • Attracts investors seeking targeted exposure to betting, alcohol, cannabis, and pharmaceutical sectors.

Branchenkontext

B.A.D. ETF operates within the asset management industry, specifically focusing on thematic ETFs that target niche sectors. The ETF's strategy of investing in betting, alcohol, cannabis, and pharmaceutical companies positions it within industries experiencing varying degrees of growth and regulatory scrutiny. The competitive landscape includes other thematic ETFs, such as ERM, GERM, GFOF, GPOW, and HART, that may focus on similar or overlapping sectors. The asset management industry is characterized by increasing demand for specialized investment products, driven by investors seeking targeted exposure to specific market trends and sectors.

Wichtige Kunden

  • Retail investors seeking exposure to specific sectors.
  • Institutional investors looking for targeted investment strategies.
  • Investors interested in the betting, alcohol, cannabis, and pharmaceutical industries.
KI-Zuversicht: 71% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

B.A.D. ETF (BAD) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer BAD verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer BAD.

Kursziele

Wall-Street-Kurszielanalyse fuer BAD.

MoonshotScore

44/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von BAD auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Was Anleger ueber B.A.D. ETF (BAD) wissen wollen

What are the key factors to evaluate for BAD?

B.A.D. ETF (BAD) currently holds an AI score of 44/100, indicating low score. Key strength: Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals).. Primary risk to monitor: Potential: Regulatory changes negatively impacting the betting, alcohol, cannabis, and pharmaceutical industries.. This is not financial advice.

How frequently does BAD data refresh on this page?

BAD prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven BAD's recent stock price performance?

Recent price movement in B.A.D. ETF (BAD) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals).. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider BAD overvalued or undervalued right now?

Determining whether B.A.D. ETF (BAD) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying BAD?

Before investing in B.A.D. ETF (BAD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding BAD to a portfolio?

Potential reasons to consider B.A.D. ETF (BAD) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals).. Additionally: Passive management approach.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of BAD?

Yes, most major brokerages offer fractional shares of B.A.D. ETF (BAD) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track BAD's earnings and financial reports?

B.A.D. ETF (BAD) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for BAD earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • The fund's performance is heavily reliant on the performance of the specific sectors it targets.
  • Regulatory changes in the betting, alcohol, cannabis, and pharmaceutical industries could significantly impact the fund's performance.
Datenquellen

Popular Stocks